Nabla Bio
YC S20We use AI to design antibodies for intractable diseases
Boston, MA, USAFounded 20218 employeeswww.nabla.bio
Team
8
Founded
2021
About
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
No open roles at this time.
Similar Healthcare startups
AbInitio Bio
The Intelligence layer for Drug Manufacturing
AI-powered Drug DiscoveryBiotechManufacturing
Open Jobs —
Team 2
Founded 2026
Diffuse Bio
Generative AI for protein design
AI-powered Drug DiscoveryDeep LearningGenerative AI
Open Jobs —
Team 10
Founded 2023
1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
AI-powered Drug Discovery
Open Jobs —
Team 20
Founded 2021
Macromoltek
Computational antibody design
AI-powered Drug DiscoveryDeep LearningTherapeutics
Open Jobs —
Team 14
Founded 2017